Akathisia Treatment
Propranolol 10-30mg two to three times daily is the first-line treatment for akathisia, with evidence supporting its efficacy over other agents. 1
First-line Approaches
Medication Adjustments
- Modify the causative antipsychotic:
Pharmacological Interventions
Beta-blockers:
Benzodiazepines:
Anticholinergics:
Second-line Treatments
5-HT2A antagonists:
Other options:
Treatment Algorithm
Initial assessment:
- Use a validated scale (e.g., Abnormal Involuntary Movement Scale) to assess severity 1
- Identify the causative medication
First steps:
Adjunctive medication (if step 1 insufficient):
Monitoring:
Special Considerations
- Elderly patients: Use lower doses due to increased sensitivity to CNS effects 1
- Patients with Parkinson's disease: Extremely sensitive to antipsychotic effects; consider pimavanserin, clozapine, or quetiapine 1
- Cardiovascular disease: Monitor for orthostatic hypotension, especially with propranolol 1
- Pregnancy: Avoid combination therapy with valproate and risperidone 1
Important Caveats
- Abrupt withdrawal of antipsychotics can worsen symptoms; changes should be gradual 1
- Second-generation (atypical) antipsychotics generally have lower risk of akathisia than first-generation agents 1
- Akathisia can significantly impact treatment adherence and quality of life 1, 2
- Evidence for tardive akathisia treatment is limited compared to acute akathisia 2
The most recent and comprehensive evidence from a 2024 network meta-analysis suggests mirtazapine, biperiden, and vitamin B6 may be more effective than propranolol for antipsychotic-induced akathisia 5, but clinical guidelines still recommend propranolol as first-line therapy 1.